Latest filing published 06 Oct 2026 for Artiva Biotherapeutics, Inc., €63k. Read the official filing
Christopher Horan appears in our data through filings on Artiva Biotherapeutics, Inc. shares, published by SEC (Form 4). Between 12 September 2024 and 5 October 2026, the trades on record add up to 9 filings.
Sales make up the whole of the open-market record (2 sales, €163k). Besides market trades, the filings include 7 share grants. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 6 October 2026 with an open-market sale (€63k) in Artiva Biotherapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations